Status:
RECRUITING
Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
Lead Sponsor:
University of Ottawa
Collaborating Sponsors:
Children's Hospital of Eastern Ontario
Alberta Children's Hospital
Conditions:
Cancer
Parent
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clinical levels of fear of cancer recurrence (FCR) affect up to 59% of adult cancer survivors. Family caregivers experience equal or greater levels of FCR, which has been linked to lower quality of li...
Detailed Description
Pilot Study: 36 parents will be recruited to participate in the study. Additionally, 3 therapists with extensive online support group experience to conduct the Parent-FORT videoconference therapy ses...
Eligibility Criteria
Inclusion Criteria:
- Parent (or primary caregiver) caring for a childhood cancer survivor (<18 years of age) of any type of cancer type, who is at least 1 months from the completion of active treatment and has not had a recurrence of their cancer
- A score of 13 or greater on the Fear of Cancer Recurrence Inventory-Short Form-Parent version (FCRI-SF-P; range 0-36), suggesting clinical levels of FCR
- Access to a computer and internet connection
- Living in Canada
Exclusion Criteria:
- Being the parent of a pediatric cancer survivor who is now 18 years of age or older
- Being the parent of a pediatric cancer survivor who has undergone hematopoietic cell transplantation and has active chronic or acute graft-versus-host disease which has not stabilized for at least 3 months
- Non-English speakers
- Currently participating in another therapist-led psychosocial therapy group
- Parent with unmanaged/undermanaged mental health disorder judged to be clinically contraindicated and/or likely to affect the group work
- To avoid violating the assumption of nonindependence of the data, only one parent/caregiver per child can participate in the study.
Key Trial Info
Start Date :
August 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 26 2027
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06872840
Start Date
August 26 2025
End Date
May 26 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa
Ottawa, Ontario, Canada, K1N6N5